ADAMTS9 and ovarian cancer: On the other hand, ADAMTS9-AS2 lncRNA was significantly reduced in ovarian cancer tissues and cell lines and it was correlated with advanced FIGO stage, lymph node metastasis, and poor overall survival of ovarian cancer patients.